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Introduction. Healthcare-associated infections (HAIs) and anti-
microbial resistance are well known major public health threats. 
The first goal of our study was to describe the prevalence of HAI, 
while the second goal was to describe the antibiotic consumption 
at our University Hospital, “P. Giaccone” in Palermo, Italy.
Methods. A standardized methodology for a combined Point 
Prevalence Survey (PPS) on healthcare-associated infections 
(HAIs) and antimicrobial use in European acute care hospital 
developed by the European Centre for Disease Prevention and 
Control (ECDC) was piloted across Europe. The teaching Hos-
pital “P. Giaccone” in Palermo, Italy, participated in the study. 
Results. Out of 328 surveyed patients, 12 (3.6%) had an 
HAI and 159 (48.5%) were receiving at least one antimicro-
bial agent. Prevalence results were highest in intensive care 
units, with 17.6% patients with HAI. Bloodstream infections 
represented the most common type (50%) of HAI. Surgical 
prophylaxis was the indication for antimicrobial prescribing 
in 59 (37.1%) out of 159 patients and exceeded 24 hours in 54 
(91.5%) cases. 
Discussion. The results suggest that in our hospital there was a 
frequent and inappropriate use of antimicrobials, especially in 
the setting of surgical prophylaxis.
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Summary
Introduction
Healthcare-associated infections (HAIs) are an impor-
tant cause of morbidity and mortality worldwide [1]. 
The annual prevalence of HAIs in Italy is estimated to 
range between 5% and 8% by year. The most frequent 
HAIs are the lower respiratory tract infections (LRTIs), 
followed by urinary tract infections (UTIs), bloodstream 
infections (BSIs) and surgical site infections (SSIs) [1]. 
In our country about 450,000-700,000 patients acquire 
at least one HAI during hospital stay [1-3]. Thus, HAI’s 
surveillance is recognized as a crucial activity for the 
prevention and control programs. 
Excessive and inappropriate use of antibacterial drugs 
is a major public health problem worldwide, since it is 
associated to an alarming increase in drug resistance 
and adverse drug reactions and causes also huge eco-
nomical costs [4]. Available international and national 
data about amount and pattern of antibiotic use in both 
community and hospital setting are not always suffi-
ciently informative because national databases may use 
different and no standardized methods to measure anti-
biotic use. To this aim, PPS (Point Prevalence Survey) 
can provide baseline information about occurrence and 
distribution of HAI and antibiotic use in healthcare in-
stitutions.
On September 2011, the teaching Hospital “Paolo Gi-
accone” of Palermo, Italy, participated to the European-
scale Prevalence Survey for the Surveillance of Health-
care-Associated Infections (HAI) and Antimicrobial 
Use in Acute Care Hospitals [2]. This project was im-
plemented by the European Center for Disease Preven-
tion and Control (ECDC) through a protocol providing a 
standardized methodology to the Member States and the 
participating hospitals. 
The specific objectives of Prevalence Survey were to es-
timate the total burden of HAI and antimicrobial use, by 
applying a standardized European methodology, and to 
disseminate the results at a local, regional, national and 
EU level.
Methods
Setting
The Teaching Hospital “P. Giaccone” of Palermo, Italy, 
is a tertiary care hospital with 575 beds, of which 497 
reserved to acute and 16 to intensive care, with nearly 
20,400 admissions annually. The number of patient-days 
per year is about 151,700. This hospital in the European-
scale Prevalence Survey of Healthcare-Associated Infec-
tions and Antimicrobial Use accounted for western Sicily.
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Point prevalence survey (PPS)
The standardized protocol for a combined Point Preva-
lence Survey (PPS) on healthcare-associated infections 
(HAIs) and antimicrobial use that we used, represents 
the final protocol (version 4) defined in 2011-2012 by 
ECDC, which carried out a review of 17 national or re-
gional point prevalence surveys of HAI (and antimicro-
bial use) in European countries (ECDC Annual Epide-
miological report 2008) [2, 5, 6]. 
A series of inclusion requirements had to be met. All 
acute care units were included, but long-term care 
units, accident and emergency (A&E) Departments, 
patients admitted to same-day treatment or surgery, the 
outpatient departments, emergency room and dialysis 
were ruled out. Data recovered for each patient aimed 
to identify an active HAI and/or the use of antimicro-
bial drugs at the time of the survey. Data had to be 
collected in a single day for each ward/unit. The total 
time frame of data collection for all units of a single 
hospital had not to exceed 2-3 weeks. Data were col-
lected using two forms: “Hospital data form” including 
general information on the type of surveyed hospital 
and “Patient data form” subdivided in three parts: the 
first one dedicated to demographic and clinical data, 
the second one describing antimicrobials use and the 
last one regarding HAI.
In the pilot study, ECDC recommended that data collec-
tion was to be carried out by experienced staff in read-
ing patient charts/notes and in HAIs’ identifying (e.g. 
infection control professionals, clinical microbiologists, 
infectious disease specialists). In particular, in our sur-
vey, data collectors (HAIs’ prevention and surveillance 
staff, residents) were previously trained by the national 
PPS coordinators to become familiar with protocol and 
case definition.
Case definition
European case definition for HAI was used according 
to previous surveillance projects (HELICS or other 
European projects), whereas case definitions from the 
National Healthcare safety, Centers for Disease Con-
trol and Prevention (CDC), were otherwise used. In the 
HAIs section, data on microorganisms and their resis-
tance phenotype were collected. Only results that were 
already available at the time of the survey were includ-
ed. Data were also collected for patients showing an ac-
tive HAI on the day of the survey. A HAI was defined 
as active when:
•	 signs and symptoms fulfilled the survey definitions 
of HAI and were present on the survey date
or
•	 signs and symptoms fulfilling the survey definitions 
of HAI had been present in the past and the patient 
was still receiving treatment on the survey date.
Definitions of antimicrobial use data
The antimicrobial-related informations were only col-
lected if patient was receiving antimicrobials at the time 
of the survey or alternatively had an active HAI. Both 
generic and brand names were allowed. The drugs in-
cluded the ATC classes J01 (antibacterials), J02 (an-
tifungals) and J04 (antimycobacterials). The route of 
administration was also recorded. The patients could 
receive systemic antimicrobials for: 
•	 community-acquired infection (CI): all infections 
already present at admission except for those corre-
lated to a previous hospitalization;
•	 healthcare infection acquired in long term care facil-
ity or chronic care hospital (LI);
•	 acute hospital acquired infection (HI): this also ap-
plied to hospital-acquired infections occurring after 
discharge and for occupational infections among 
staff of the structure;
•	 Surgical Prophylaxis (SP): any single dose of an 
antimicrobial agent given within the 24-hour pe-
riod before 8:00 am on the day of the survey. This 
time window for surgical prophylaxis allowed 
for distinguish single dose prophylaxis, one day 
prophylaxis or prophylactic doses given over more 
than one day; 
•	 Medical Prophylaxis (MP): it included antibiotic 
therapy administered to prevent a disease or its re-
currence;
•	 other indications (e.g. use of erythromycin as a pro-
kinetic agent);
•	 unknown indication/reason (assessed during PPS);
•	 unknown/missing information on indication no veri-
fied during PPS.
Results
A total of 328 patients, of whom 161 females (49.1%), 
were included in the PPS. Twenty-one patients were in-
fants aged 0-10 months. The mean age of the remain-
ing 307 patients was 61.8 [standard deviation (SD) 19.4] 
years for females and 60.4 (SD 18.8 years) for males. 
One hundred ninety patients out of 328 were hospital-
ized in clinical medicine departments (57.9%), 112 in 
surgical departments (34.1%) and 26% in intensive care 
units (ICUs).
Twelve (3.6%) out of the 328 patients had an HAI. One 
patient had a triple healthcare infection, so the total burden 
of HAIs was 14. BSIs represented the commonest type 
of HAI (7 out of 14), followed by UTIs (four out of 14), 
pneumonia, decubitus ulcer and SSIs. One (7.1%) central 
vascular catheter (CVC)-related infection was also iden-
tified. All UTIs were occurring in patients with urinary 
catheter. All of the six BSIs arose in patients with at least 
an invasive device in situ (CVC and/or peripheral vascular 
catheter, PVC) within for at least 48-hour. Prevalence was 
highest in ICUs (17.6%). In the department of gastroenter-
ology two out of 17 patients had an active infection at the 
moment of survey similarly to the Department of Clini-
cal Medicine Respiratory, where one out of nine patients 
had an HAI. The remaining infections were detected in the 
General Medicine ward (three out of 33 patients), Ortho-
pedics and Traumatology ward (one out of 11 patients), 
Hematology (one out of 14 patients) and Emergency Sur-
gery ward (one out of 20 patients had an HAI).
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Overall, 159 (48.5%) out of 328 of the surveyed patients 
were prescribed one or more antimicrobials. Among the 
patients receiving at least one antimicrobial, 98 (61.6%) 
out of 159 were administrated with a single agent, 47 
(29.5%) two and 14 (8.8%) received three agents. Over-
all 59 (37.1%) patients were prescribed antibiotics for 
surgical prophylaxis, 58 (36.5%) for a community infec-
tions, 27 (17.0%) for medical prophylaxis, 12 (7.5%) for 
HAI, three (1.9%) for LI (Tab. I).
In 36 out of 73 (49.3%) of the cases of SP, cephalo-
sporins were used, alone or in combination with other 
agents, followed by quinolones 16.4% (12 cases) and 
metronidazole 13.7% (10 cases) (Tab.  II). Among 3rd 
Tab. II. distribution of antimicrobial agents (ATC* 4th levels) by main indication for use, eCdC pilot point prevalence survey, 2011 (n = 223 anti-
microbial agents).
 
All indication Treatment
Surgical 
prophylaxis
Medical 
prophylaxis
n (%) n (%) n (%) n (%)
Antimicrobial agents, total 223 (100) 113 (100) 73 (100) 37 (100)
Top antimicrobial agents at ATC 4th level
 Fluoroquinolones (J01mA) 56 (25.1)  34 (30.1) 12 (16.4) 10 (27.0)
 Third-generation cephalosporins (J01dd) 55 (24.6) 12 (10.6) 35 (47.9) 8 (21.6)
 First-generation cephalosporins (J01dB) 1 (0.4) − 1 (1.4) −
 Nitroimidazole derivates (p01AB) 27 (12.1) 11 (9.7) 10 (13.7) 6 (16.2)
 Combinations of penicillins, incl.β-lactamase inhibitors 
(J01Cr)
18 (8.1) 11 (9.7) 4 (5.4) 3 (8.1)
 Combination of sulfonamides and trimethoprim (J01CA) 10 (4.4) 4 (3.5) 2 (2.7) 4 (10.8)
 macrolides (J01FA) 9 (4.0) 6 (5.3) − 3 (8.1)
 glycopeptide antibacterials (J01XA) 9 (4.0) 9 (7.9) − −
 Aminoglycosides (J01gB) 8 (3.6) 4 (3.5) 4 (5.4) −
 penicillins, extended spectrum without anti-pseudomonal 
activity (J01CA)
8 (3.6) 6 (5.3) 2 (2.7) −
 Carbapenems (J01dh) 7 (3.1) 6 (5.3) 1 (1.4) −
 Antidiarrheals, intestinal anti-inflammatory/anti-infective 
agents (A07AA)
5 (2.2) 3 (2.6) − 2 (5.4)
 Triazole derivates (J02AC) 3 (1.3) 3 (2.6) − −
 Antimycobacterials for treatment of tuberculosis (J04A) 2 (0.8) 2 (1.7) − −
 Tetracyclines (J01AA) 1 (0.4) 1 (0.8) − −
 Other antibacterials (J01XX) 3 (1.3) 1 (0.8) 1 (1.4) 1 (2.7)
* Anatomical Therapeutic Chemical
Tab. I. pattern of administration of antibiotics and indications of treatment in the surveyed patients during the ppS, 2011.
Indication of treatment
Treated patients
(n. 159)
Number of antimicrobials used
1 > 1
n* %⁺ n≠ %¹ n≠ %¹
medical prophylaxis 27 16.9% 18 66.6% 9 33.4%
Surgical prophylaxis 59 37.1% 42 71.2% 17 28.8%
Community infection 58 36.5% 36 62.1% 22 37.9%
healthcare-associated infection 12 7.5% 2 16.6% 10 83.4%
Long-term hospital-acquired infection 3 2.0% − − 3 100.0%
eCdC: european Centre for disease prevention and Control. 
* Total of patients treated for relative indication. 
⁺ percent of the total.
≠ patients receiving the indicated number of antimicrobial agents for each indication of treatment.
¹ percent each within category.
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generation cephalosporins, ceftriaxone, was the most 
frequently used.
In MP the quinolones were administered at a rate of 
27.0% (10 out of 37), cephalosporins of 21.6% (8 out 
of 37) and metronidazole of 16.2% (6 out of 37). Of the 
59 patients treated for surgical prophylaxis, only in one 
case the antibiotics were administered in single dose 
(1.7%), while in four cases for one day (6.8%) and in 
all the other cases (54 cases, 91.5%) for more than one 
day. In these last cases, the antibiotic administration was 
also prolonged after surgery. One antibiotic was admin-
istered to 37 (68.5%) out of 54 patients, while more than 
one antibiotic was given to the remaining 17 (31.5%).
Data on causal agents and their respective resistant phe-
notype were included only if they were already available 
on the date of the survey. Therefore, data on the species 
of microorganisms causing HAI were unavailable, ex-
cept for six cases. Enterobacteriaceae (E. cloacae) and 
enterococci (E. faecalis and E. faecium) were associated 
with urinary tract, blood, decubitus ulcers, including 
both superficial and deep infections and SSI. One BSI 
was associated with Cytomegalovirus. Candida albicans 
and Acinetobacter baumannii were also identified. This 
last one affected three infection sites in a single patient 
(decubitus ulcer, bloodstream and urinary tract). Resis-
tance to third generation cephalosporin and carbapenem 
was reported for E. cloacae.
Discussion
HAIs are a serious problem, contributing heavily to the 
burden of the hospital costs [7]. These infections have a 
negative impact on patient because of the worsening of 
underlying medical condition and the increased morbid-
ity and mortality [7]. 
The rapidly escalating prevalence of antimicrobial resis-
tance is a global concern. The reduced susceptibility to 
most current of available antimicrobial agents coupled 
with the progressive shortage of newly approved com-
pounds is a worrisome situation  [7]. Major problems 
are encountered for a growing number of Gram-positive 
organisms (i.e., Staphylococcus aureus, Streptococcus 
pneumoniae, Enterococcus spp.) and Gram-negative 
pathogens (i.e., Pseudomonas aeruginosa, Acineto-
bacter baumannii, Klebsiella pneumoniae) [7]. Serious 
infections caused by resistant bacteria do not respond to 
therapy and are often associated with worse outcomes, 
including increased rates of complications, additional 
costs, higher associated mortality rates and prolonged 
hospital stays [8].
HAIs’ prevalence of 3.6% observed in our survey is 
lower than that reported in other European studies and 
that observed in 2008 (6.7%) in the same hospital. The 
limits of the HAI’s estimate by PPS are well known. 
However, because case-mix and admission rules are not 
changed in the last years, it can be presumed that some 
prevention and control interventions have been to some 
extent effective. In particular
some guidelines were issued to implement infection 
control procedures, such as Antibiotic perisurgical pro-
phylaxis in adults, Ambulances hygiene, handwash-
ing (Clean care is safer care), Isolation measures in the 
AOUP P. Giaccone, Palermo, isolation of patients with 
colonization/infection by multi-resistant pathogens. So 
healthcare workers training programs were carried out 
as well.
The European prevalence has been estimated to be 7.1% 
by ECDC, based on a review of 30 national or multi-
centre PPS in 19 countries in its annual epidemiologi-
cal report for 2008 [4, 6]. However an important issue 
that should be considered for the interpretation of the 
epidemiological results of this and future surveys is the 
standardization of data collection in participating hos-
pitals to compare results between hospitals, regions and 
countries. Indeed, HAI prevalence may depend on dif-
ferences in methodology and patients case-mix and not 
only on performance variations. 
High rates of antibiotic usage were observed in our 
hospital. In particular our survey revealed use of broad 
spectrum antibiotics, sometimes combined in multidrug 
protocols, because of emergence of antibiotic-resistant 
microorganisms [9]. On the other hand, due to the wide-
spread diffusion of MDR organisms in our healthcare 
settings, it is often necessary to start an initial antibiotic 
therapy with multidrug protocols or last resource mol-
ecules, such as colistin. New diagnostic methods that al-
low to obtain microbiological confirmation in short time 
could be very useful. It is known that the excessive and 
unnecessary use of antibiotics is the main driving force 
of the high rates of drug resistant infections we are see-
ing in recent years [10, 11]. 
The results of this survey confirm those of a parallel 
analysis with another classical approach in which the 
antibiotic use in the hospital was measured by evaluat-
ing the numbers of defined daily doses (DDD) (Malta R 
et al., 2010) for 100 bed days or for number of admis-
sions. The DDD consumed in 2011 were in fact 82.06 as 
per 100 bed-days and 5.41 per admission. For the surgi-
cal wards, overall the DDD were 94.00 per100 bed-days 
and 5.98 per admission; quinolones accounted for 25.6% 
of the DDD consumed, cephalosporins for 23.7%, peni-
cillins for 16.2% and metronidazole for 14.4%. More-
over, DDD consumed for 100 bed-days in our hospital 
proved to be higher than those observed in a sample of 
five hospitals in Emilia Romagna despite increasing by 
18% in the three years period, 64.9 DDD/100 bed days 
in 2002 to 76.7 in 2004 [9, 12, 14]. 
Results showed also that a significant area of antibac-
terial overuse was SP. According to the international 
consensus, antibiotic prophylaxis in surgery involves 
the administration of an antibacterial agent for a very 
short time, temporally located just before the beginning 
of intervention  [12]. However, our study revealed that 
the antibiotics were used for longer intervals of times. 
A reason of inappropriate antibacterial drug use was the 
frequent administration as SP of drugs, such as 3rd gen-
eration cephalosporins, which are not recommended for 
surgical prophylaxis and should be reserved to the treat-
ment of severe active infections. 
Our study has some limitation. Indeed the PP study de-
sign has some inherent limits, including reduced periods 
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of observation and the possibility of obtaining biased 
results. It has the advantage to be very economical in 
terms of both time and human and financial resources. 
Repeated PPS represent a more feasible alternative for 
hospital-wide surveillance of all HAIs, while still allow-
ing the estimation of HAIs burden in acute hospitals, and 
helping to prioritize areas requiring interventions  [1]. 
Therefore, although it was carried out in full compliance 
with the European protocol, the study has likely some 
limitations inherent to the study design. Continuous sur-
veillance, especially prospective active surveillance, is 
the gold standard to improve patient safety. 
The HAI prevalence rate detected in our PPS was lower 
than expected. However, our investigation highlighted a 
large misuse of antibacterial drugs, in particular in the 
area of SP. Prophylactic use of antibiotics in surgery is 
an example of how a potentially useful practice can be 
misused. More in general, inappropriate antibiotic use 
can lead to increased morbidity, prolonged hospital stay 
and need for more expensive drugs [13, 14]. The main 
aim of antibiotic stewardship is to bring a change in pre-
scribing which could lead to control of drug resistance, 
decreased costs and improved quality of antibiotic use. 
Approaches that have to be, also locally, adopted in-
clude educational programs, development of prescribing 
n Received on May 16, 2013. Accepted on October 22, 2013.
n Correspondence: M. Valeria Torregrossa, Department of Sciences 
for Health Promotion and Mother-Child Care “G. D’Alessandro”, 
University of Palermo, via Del Vespro 133, 90127 Palermo (PA), 
Italy - Tel. +39 091 6553609 - Fax +39 091 6553109 - E-mail: 
m.v.torregrossa@unipa.it
guidelines (e.g. Clean Care is Safer Care, WHO) [15], 
monitoring of drug resistance patterns, turning to restric-
tive hospital formularies [16, 17]. 
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